• Latest Posts

Scancell signs agreement with Genmab

Oxford BioTherapeutics enters into antibody agreement with Genmab

License submitted to FDA for drug to help those with large B-cell lymphoma

The Billion-Euro European Biotech Companies in 2022

Delayed IPOs and Market Drops Batter Biotech Stocks

ADC Approval Buoys Spirits in Cancer Treatment Space


EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls

The 21 European Biotech Companies To Watch in 2021

A Year to Remember: The Biggest European Biotech News in 2020

AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal

European Biotechs Showcase Multiple Sclerosis Treatments in Stockholm